Type 2 diabete?s. Non-insulin-dependent diabetes mellitus
Conditions
Interventions
Intervention 1: The control group will only receive an educational booklet, and a systematic intervention program will not be given. They have just one session (30 minutes) by sports medicine speciali
Lifestyle
The control group will only receive an educational booklet, and a systematic intervention program will not be given. They have just one session (30 minutes) by sports medicine specialist about health
The intervention group: The 6-week group therapy will be provided in 6 sessions once a week by sports medicine specialist (2 hours) consisted of: health screening (blood pressure and body weight check
Sponsors
Tehran University of Medical Sciences (Research Department)
Eligibility
Sex/Gender
All
Age
30 Years to 70 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: known history of type 2 diabetes, age more than 30 years old, not engaged in physical activity more than 2 hours/week, not receiving insulin, the absence of ST changes in ECG; history of chest pain or pressure, dyspnea on exertion, unexplained gastrointestinal complaints; uncontrolled BP (resting systolic BP >200mmHg or diastolic BP >110mmHg); resting tachycardia (100 beats/min); absence of clinical findings of diabetic micro- or macrovascular complications (retinopathy, autonomic neuropathy, nephropathy), Not orthopedic problem for patient’s activity, ability to read and speak in Persian Exclusion criteria: taking glucocorticoids, absence in more than one session of group therapy session
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Quality of life. Timepoint: before intervention and after 6 weeks of intervention. Method of measurement: The short form health survay (SF-36).;TG. Timepoint: before intervention and after 6 weeks of intervention. Method of measurement: Blood sample.;HDL. Timepoint: before intervention and after 6 weeks of intervention. Method of measurement: Blood sample.;LDL. Timepoint: before intervention and after 6 weeks of intervention. Method of measurement: Blood sample.;Total cholestrol. Timepoint: before intervention and after 6 weeks of intervention. Method of measurement: Blood sample.;Diastolic pressure. Timepoint: before intervention and after 6 weeks of intervention. Method of measurement: Sphygmomanometer.;FBS. Timepoint: before intervention and after 6 weeks of intervention. Method of measurement: Blood sample.;Systolic blood pressure. Timepoint: before intervention and after 6 weeks of intervention. Method of measurement: Sphygmomanometer.;Hb A1c. Timepoint: before intervention and after 6 weeks of intervention. Method of measurement: Blood sample.;Weight. Timepoint: before intervention and after 6 weeks of intervention. Method of measurement: scale.;BMI. Timepoint: before intervention and after 6 weeks of intervention. Method of measurement: weight(kg)/Square of height(meter).;Waist circumference. Timepoint: before intervention and after 6 weeks of intervention. Method of measurement: meter.;Physical functioning. Timepoint: before intervention and after 6 weeks of intervention. Method of measurement: The short form health survey(SF-36).;Role physical. Timepoint: before intervention and after 6 weeks of intervention. Method of measurement: The short form health survey(SF-36).;Social functioning. Timepoint: before intervention and after 6 weeks of intervention. Method of measurement: The short form health survey(SF-36).;Mental health. Timepoint: before intervention and after 6 weeks of intervention. Method of measurement: The short form health survey(SF-36).;Bodily | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactHaleh Dadgostar, MD
Tehran University of Medical Sciences
Outcome results
None listed